HemaSphere (Dec 2020)

Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1

  • Julius Lukes, Jr.,
  • Lucie Winkowska,
  • Martina Zwyrtkova,
  • Julia Starkova,
  • Lucie Sramkova,
  • Jan Stary,
  • Jan Trka,
  • Jan Zuna,
  • Marketa Zaliova

DOI
https://doi.org/10.1097/HS9.0000000000000489
Journal volume & issue
Vol. 4, no. 6
p. e489

Abstract

Read online

No abstracts available.